Measuring macular pigment in vivo;Le pigment maculaire et sa mesure in vivo

Journal Francais d'Ophtalmologie

Volumn 31, Issue 4, 2008, Pages 445-453

  Rougier, M B ^a   Delyfer, M N ^a   Korobelnik, J F ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

Heterochromic flicker photometry; Lutein; Macular pigment; Raman spectroscopy; Reflectance; Zeaxanthin

Indexed keywords

EID: 43949111042     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0181-5512(08)71444-X     Document Type: Article

References (40)

1. Whitehead AJ, Mares JA, Danis RP. Macular pigment. A review of current knowledge. Arch Ophthalmol, 2006; 124:1038-45.
2. Wald G. Human vision and the spectrum. Science, 1945;101:653-8.
3. Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vis Res, 1985;25:1531-5.
4. Bernstein PS, Balashov NA, Tsong ED, Rando RR. Retinal tubulin binds macular carotenoids. Invest Ophthalmol Vis Sci, 1997;38:167-75.
5. Bhosale P, Larson AJ, Frederick JM, Southwick K, Thuli CD, Bernstein PS. Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem, 2004;279:49447-54.
6. Schültze M. Ueber den gelben Fleck der Retine, seinen Einfluss auf normales Sehen und auf Farbenblindheit. Bonn: Von Max Cohen and Sohn; 1866.
7. Engles M, Wooten B, Hammond B. Macular Pigment: a test of the acuity hypothesis. Invest Ophthalmol Vis Sci, 2007;48:2922-31.
8. Stingham JM, Hammond BR. The glare hypothesis of macular pigment function. OptomVis Sci, 2007;84:859-64.
9. Sparrow JR, Boulton M. RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res, 2005;80:595-606.
10. Weiter JJ, Delori FC, Wing GL, Fitch KA. Central sparing in annular macular degeneration. Am J Ophthalmol, 1988; 106:286-92.
11. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci, 2001;42:235-40.
12. Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton M. Macular pigment and risk of age-related macular degeneration in subjects from a nothern European population. Invest Ophthalmol Vis Sci, 2001;42:439-46.
13. Boulton M, Dontsov A, Jarvis-Evans J, Ostrovsky M, Svistunenko D. Lipofuscin is a photoinducible free radical generator. J Photochem Photobiol B, 1993; 19:201-4.
14. Kim SR, Nakanishi K, Itagaki Y, Sparrow JR. Photooxidation of A-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp Eye Res, 2006;82:828-39.
15. Sundelin SP, Nilsson SE, Brunk UT. Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxydants. Free Radic Biol Med, 2001;31: 217-25.
16. Delcourt C, Carrière C, Delage M, Barberger-Gateau P, Schalch W and the POLA study Group. Plasma Lutein and Zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA study. Invest Ophthalmol Vis Sci, 2006; 47:2329-35.
17. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, et al . for the Eye Disease Case-Control Study Group. Dietary carotenoids, Vitamins A, C and E, and advanced age-related macular degeneration. JAMA, 1994;272:1413-21.
18. Gale CR, Hall NF, Phillips DI, Martyn CN. Lutein and Zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci, 2003;44: 2461-5.
19. Eye Disease Case-Control Study Group. Antioxydant status and neovascular age-related macular degeneration. Arch Ophthalmol, 1993;111:104-9.
20. Moeller SM, Parekh N, Tinker L, Ritenbaugh C, Blodi B, Wallace RB, et al . Associations between intermediate age-related macular degeneration and Lutein and Zeaxanthin in the Carotenoids in age-related eye disease study (CAREDS). Arch Ophthalmol, 2006;124:1151-62.
21. Hammond BR, Curren-Celentano J, Judd S, Fuld K, Krinsky NI, Wooten BR, et al . Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vis Res, 1996;36:2001-12.
22. Ciulla TA, Curren-Celentano J, Cooper D. Macular pigment optical density in a Midwestern sample. Ophthalmology, 2001;108:730-7.
23. Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA. Macular pigment density measured by autofluorescence spectometry: comparaison with reflectometry and heterochromatic flicker. J Opt Soc Am, 2001;18: 1212-30.
24. Hammond BR, Ciulla TA, Snodderly DM. Macular pigment optical density is reduced in obeses subjects. Invest Ophthalmol Vis Sci, 2002;43:47-50.
25. Bone RA, Landrum JT, Guerra LH, Ruiz CA. Lutein and Zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr, 2003;133: 992-8.
26. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci, 2000;41: 3322-6.
27. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. A one-year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res, 1997;65:57-62.
28. Trieschmann M, Beatty S, Nolan JM, Hense HW, Heimes B, Austermann U, et al . Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res, 2007;84:718-28.
29. Bone RA, Landrum JT, Cao Y, Howard AN, Alvarez-Calderon F. Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin. Nutr Metab, 2007;11: 4-12.
30. Snodderly DM, Mares JA, Wooten BR, Oxton L, Gruber M, Ficek T; The CAREDS macular pigment study group. Macular pigment measurement by heterochromatic flicker photometry in older subjects: the carotenoids and age-related eye disease study. Invest Ophthalmol Vis Sci, 2004;45:531-8.
31. Bone RA, Landrum JT. Heterochromatic flicker photometry. Arch Biochemistry Biophysics, 2004;430:137-42.
32. Robson AG, Moreland JD, Pauleheikoff D, Morrissey T, Holder GE, Fitkze FW, et al . Macular pigment density and distribution: comparison of fundus autofluorescence with minimum motion photometry. Vision Research, 2003;43: 1765-75.
33. Bernstein PS, Yoshida MD, Katz N, McClane RW, Gellerman W. Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci, 1998;39:2003-11.
34. Neelam K, O’Gorman N, Nolan J, O’Donovan O, Wong HW, Au Eong KG, et al . Measurement of macular pigment: Raman spectroscopy versus Heterochromatic flicker photometry. Invest Ophthalmol Vis Sci, 2005;46:1023-32.
35. Hogg RE, Anderson RS, Stevenson MR, Zlatkova MB, Chakravarthy U. In vivo macular pigment measurements: a comparison of resonance Raman spectroscopy and versus Heterochromatic flicker photometry. Br J Ophthalmol, 2006;91:485-90.
36. Robson AG, Harding G, van Kuijk FJ, Pauleheikoff D, Holder GE, Bird AC, et al . Comparison of fundus autofluorescence and minimum-motion measurements of macular pigment distribution profiles derived from identical retinal areas. Perception, 2005;34:1029-34.
37. Bour LJ, Koo L, Delori FC, Apkarian P, Fulton AB. Fundus photography for measurement of macular pigment density distribution in children. Invest Ophthalmol Vis Sci, 2002;43:1450-5.
38. Wüstemeyer H, Moessner A, Jahn C, Wolf S. Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope. Graefe’s Arch Clin Exp Ophthalmol, 2003;241:647-51.
39. Berendschot TT, van Norren D. Macular pigment shows ringlike structures. Invest Ophthalmol Vis Sci, 2006;47: 709-14.
40. Wolf-Schnurrbusch UE, Röösli N, Veyermann E, Heldner MR, Höhne K, Wolf S. Ethnic differences in macular pigment density and distribution. Invest Ophthalmol Vis Sci, 2007;48: 3783-7.